Ignite Creation Date:
2024-05-06 @ 7:08 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05905055
Status:
RECRUITING
Last Update Posted:
2023-10-26
First Post:
2023-03-02
Brief Title:
P3 Study to Assess Efficacy and Safety of CefepimeNacubactam and AztreonamNacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales
Sponsor:
Meiji Seika Pharma Co Ltd
Organization:
Meiji Seika Pharma Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-22
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-02
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-02
First Submit QC Date:
June 6 2023
Study First Post Date:
2023-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-25
Last Update Post Date:
2023-10-26
Last Update Post Date Type:
ACTUAL